Adamo, Vincenzo
 Distribuzione geografica
Continente #
EU - Europa 187
NA - Nord America 111
AS - Asia 104
SA - Sud America 22
AF - Africa 7
Totale 431
Nazione #
US - Stati Uniti d'America 107
IE - Irlanda 47
IT - Italia 42
SG - Singapore 40
DE - Germania 27
SE - Svezia 26
HK - Hong Kong 24
CN - Cina 22
BR - Brasile 20
RU - Federazione Russa 17
FI - Finlandia 11
KR - Corea 6
VN - Vietnam 6
BJ - Benin 4
FR - Francia 4
CA - Canada 3
IR - Iran 3
PL - Polonia 3
ZA - Sudafrica 3
BA - Bosnia-Erzegovina 2
ES - Italia 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
IN - India 1
JP - Giappone 1
MX - Messico 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 431
Città #
Dublin 47
Hong Kong 24
Ashburn 16
Beijing 16
Munich 14
West Jordan 10
Milan 8
Singapore 8
Helsinki 7
Turin 7
Seoul 6
Andover 5
Frankfurt am Main 5
Bremen 4
Buffalo 4
Cotonou 4
Ho Chi Minh City 4
Lawrence 4
Los Angeles 4
Princeton 4
Sesto San Giovanni 4
Stockholm 4
Turku 4
Wilmington 4
Pescara 3
Porto Alegre 3
São Paulo 3
Borgomanero 2
Johannesburg 2
Magnago 2
Modena 2
New York 2
Toronto 2
Venice 2
Wroclaw 2
Aparecida de Goiânia 1
Ardabil 1
Atlanta 1
Barreiros 1
Biella 1
Bijeljina 1
Boston 1
Brooklyn 1
Brussels 1
Cajamar 1
Castelnuovo Scrivia 1
Chicago 1
Curitiba 1
Fermo 1
Guarulhos 1
Houston 1
Hải Dương 1
Ibirataia 1
Ituzaingó 1
Jacksonville 1
Jaguariúna 1
Las Vegas 1
Leawood 1
Maldonado 1
Manaus 1
Maricá 1
Minneapolis 1
Montfort-sur-Meu 1
Montreal 1
Mumbai 1
Nuremberg 1
Palmas 1
Pelotas 1
Phoenix 1
Pompéu 1
Quảng Ngãi 1
Redondo Beach 1
Rolim de Moura 1
Roubaix 1
Salvador 1
San Mateo 1
Santa Clara 1
Sarajevo 1
Sofia 1
Tashkent 1
Tianjin 1
Tokyo 1
Tuxtla Gutiérrez 1
Warsaw 1
Woodbridge 1
Zanjan 1
Totale 293
Nome #
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort 90
Acute diverticulitis management: evolving trends among Italian surgeons. A survey of the Italian Society of Colorectal Surgery (SICCR) 83
Post-progression outcomes of NSCLC patients with PD-L1 expression ≥ 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study 73
Predictive ability of a drug-based score in patients with advanced non–small-cell lung cancer receiving first-line immunotherapy 73
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy 60
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 58
Totale 437
Categoria #
all - tutte 2.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.667


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 3 2 0
2021/202234 6 0 1 4 6 0 4 1 0 4 4 4
2022/202360 12 2 4 0 4 4 3 0 31 0 0 0
2023/202459 2 2 9 2 8 7 10 1 0 11 2 5
2024/2025152 0 1 8 0 1 37 5 27 26 0 14 33
2025/2026127 21 14 19 37 35 1 0 0 0 0 0 0
Totale 437